Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
138.22B | 130.18B | 123.48B | 118.01B | 120.81B | Gross Profit |
33.64B | 31.92B | 30.98B | 29.38B | 30.25B | EBIT |
8.08B | 7.86B | 8.25B | 7.29B | 7.91B | EBITDA |
13.13B | 11.86B | 12.21B | 10.94B | 11.32B | Net Income Common Stockholders |
5.81B | 6.11B | 5.81B | 5.48B | 5.25B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
31.68B | 37.00B | 36.16B | 35.24B | 32.59B | Total Assets |
114.93B | 110.78B | 105.90B | 102.18B | 97.03B | Total Debt |
1.82B | 2.30B | 2.72B | 3.12B | 3.35B | Net Debt |
-29.17B | -33.77B | -33.08B | -32.03B | -28.85B | Total Liabilities |
28.14B | 28.56B | 28.38B | 28.30B | 28.21B | Stockholders Equity |
86.18B | 81.65B | 77.00B | 73.39B | 68.36B |
Cash Flow | Free Cash Flow | |||
-664.00M | 2.37B | 5.99B | 5.95B | 5.34B | Operating Cash Flow |
8.04B | 8.59B | 10.13B | 9.23B | 8.28B | Investing Cash Flow |
-10.21B | -6.24B | -6.74B | -4.20B | -3.51B | Financing Cash Flow |
-3.20B | -2.43B | -2.90B | -1.97B | -2.92B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
71 Outperform | $1.44T | 14.87 | 5.95% | 2.85% | -7.84% | -45.99% | |
67 Neutral | $75.22B | 12.05 | 2.72% | 7.65% | 6.79% | ||
65 Neutral | $47.11B | 4.47 | 3.38% | -6.39% | -12.04% | ||
64 Neutral | ¥24.01B | 28.26 | 3.43% | -4.73% | -81.56% | ||
64 Neutral | $1.85T | 20.75 | 5.34% | 1.59% | -9.90% | -56.78% | |
62 Neutral | $408.28B | 17.89 | 5.24% | 1.79% | -3.83% | -41.83% | |
51 Neutral | $5.31B | 3.39 | -40.42% | 2.90% | 18.11% | 2.25% |
TOKAI Corp. announced an expected extraordinary loss of 1.87 billion yen due to impairment losses on fixed assets related to its dispensing pharmacy and elderly care equipment businesses. Despite this, the company revised its earnings forecast upward for net sales, operating profit, and ordinary profit due to strong performance in its core rental business and recent acquisitions. However, the profit attributable to owners of the parent is expected to decrease due to the impairment losses. The year-end dividend remains unchanged, resulting in an annual dividend of 58 yen per share.